Skip to main content
. 2021 Aug 26;19:367. doi: 10.1186/s12967-021-03042-7

Table 4.

Relationship between SLC7A11 or nuclear NRF2 expression and clinical response to CRT

Treatment response
CR + PR SD + PD P-value
Nuclear NRF2 Low expression (%) 49 (74.2) 17 (25.8) 0.002
High expression (%) 29 (47.5) 32 (52.5)
SLC7A11 Low expression (%) 46 (70.8) 19 (29.2) 0.027
High expression (%) 32 (51.6) 30 (48.4)